Pharmafile Logo
Pharmafocus logo
Advanced Search

Turkey

Showing 6 posts of 6 posts found.

turkey_flag

Diurnal joins Er-Kim to distribute cortisol deficiency treatments in Turkey

January 13, 2021
Research and Development Diurnal, Diurnal Group, Er-Kim, Turkey

Diurnal Group, a specialty pharmaceutical company targeting patient needs in chronic endocrine diseases, has announced a distribution agreement with Er-Kim, …

News
Takeda image

Takeda acquires Turkish firm Neutec

February 24, 2015
Sales and Marketing Takeda, Turkey, gastroenterology, neutec, respiratory, turkish

Takeda has signed an agreement to acquire one of Turkey’s leading pharma firms Neutec in a $120 million deal. The …

News

Turkey ‘can be pharma R&D, production hub by 2023’, says PwC

October 23, 2012
Manufacturing and Production, Research and Development, Sales and Marketing R&D, Turkey, pwC

Despite lagging behind its peers among ‘pharmerging’ economies, Turkey has the potential to become a major R&D and production hub …

News

Novartis to construct pharma plant in Turkey

April 2, 2012
Manufacturing and Production Novartis, Turkey, manufacturing

Novartis has selected Turkey as its headquarters for central Asia, the Middle East and Africa and intends to set up …

News

Lilly considering a stake in Turkish drugmaker

September 6, 2011
Manufacturing and Production, Research and Development, Sales and Marketing MN Pharmaceuticals, Turkey, lilly, research and development news

Eli Lilly is reportedly eyeing up a partnership with Turkish drugmaker Mustafa Nevzat Ilac Sanayi (MN Pharmaceuticals) in order to …

News

Turkey: volatility and growth

May 24, 2010
Sales and Marketing Turkey, em

The economic woes of Greece are currently the most worrying problem within the European Union’s single currency region the Eurozone, …

Feature

Latest content

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024

Intra-Cellular Therapies shares phase 3 results for major depressive disorder therapy

April 17, 2024

Novartis shares new data about Fabhalta for IgAN treatment

April 16, 2024